Researchers find a promising approach to remove amyloid plaques in Alzheimer’s disease

FHS
April 3, 2024
7:06 pm

Alzheimer’s disease starts with a sticky protein called amyloid beta that builds up into plaques in the brain, setting off a chain of events that results in brain atrophy and cognitive decline.

JNJ-6358 by Johnson & Johnson for Solid Tumor: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 26, 2023

PharmAla Biotech and Filament Health Announce Release of Second Batch of GMP MDMA Capsules | Psychedelic Invest

PharmAla Biotech Holdings Inc. (“PharmAla”) (CSE:MDMA)(OTCQB:PMBHF), a Canadian biotechnology company dedicated to the research and development of clinical-grade LaNeo™ MDMA and novel MDXX compounds, and

November 16, 2023

FDA to start review of subcutaneous Entyvio for Crohn’s disease – Pharmaceutical Technology

Entyvio led to a significant decrease in Chron’s Disease Activity Index compared to a placebo after six weeks of treatment. Image credit: Shutterstock/Melnikov Dmitriy. The

September 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.